AbstractOral cancer is the 6th most common type of cancer in Thailand. The early stage, oral potentially malignant disorder (PMD), can be cured if detected and treated immediately. Currently, more than 80 percent of patients were diagnosed in the advanced stage. Hence, there is the oral cancer screening program for early detection among Thai popula

Cost-utility and budget impact analyses were performed to estimate the costs of hematopoietic stem cell transplantation compared to blood transfusions combined with iron chelating therapy (BT-ICT), The results found that the provision for HSCT for severe thalassemic patients was likely to be costeffective when provided to younger patients. The gove

Boonying Siribumrungwong1, Pinit Noorit2, Chumpon Wilasrusmee3, Pattara Leelahavarong4, Ammarin Thakkinstian5 and Yot Teerawattananon4 Abstract Objectives: To conduct economic evaluations of radiofrequency ablation, ultrasound-guided foam sclerotherapy and surgery for great saphenous vein ab

Abstract BACKGROUND: Recently, the second-generation tyrosine kinase inhibitors dasatinib and nilotinib have emerged as alternative treatments in patients with chronic myeloid leukemia (CML) who are resistant to or intolerant of imatinib. OBJECTIVE: This article aimed to assess the cos

Imatinib, the first tyrosine kinase inhibitor (TKI) has been used widely as a first-line treatment for newly diagnosed CML patients. Approximately 20-30% of CML patients are resistant or intolerant to the drug, and half of these cases are due to a gene mutation in the ABL domain. Recently, second generation TKIs have emerged, such as dasatinib and

The objective of this study is to analyze the impact on the national budget of Chemotherapy as adjuvant therapy. The costeffectiveness and cost-utility of providing adjuvant therapy for stage III colorectal cancer patients were estimated. The regimens with and without Oxaliplatin for stage III colorectal cancer patients were compared. The 5-Fluorou

Background: In Thailand, there has been no economic evaluation study of adjuvant chemotherapy for stage III colon cancer patients after resection. Objective: This study aims to evaluate the cost-utility of all chemotherapy regimens currently used in Thailand compared with the adjuvant 5-fluorouracil

The objective of this study is to estimate the cost-utility analysis of the cholinesterase inhibitors (i.e., donepezil, galantamine and rivastigmine) compared with no drug treatment in patients with mild to moderate alzheimer’s disease (AD) in Thailand based on the societal and governmental perspectives and to estimate the budget impact of the ch

Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: Protection at what price in the Thai context? Wantanee Kulpenga, b, , , , Pattara Leelahavaronga, , Waranya Rattanavipaponga, , Vorasith Sornsrivichaib, , Henry C. Baggettc, , Aronrag Meeyaia, d, , , Warunee Punpaniche, ,

A model-based economic evaluation was performed to estimate costs as well as outcomes of vaccination with PCV10 and PCV13 compared to ‘no vaccination’. This study considered two commonly recommended regimens: two-dose primary series at 2 and 4 months of age plus a booster dose at age 13 months (2+1) and three-dose primary series at 2, 4 and 6 m